"Rifaximin was associated with decreased blood ammonia levels, lower incidence of OHE, and fewer hospitalizations in Japanese patients with HE. In addition, serum albumin level was an important predictor of the efficacy of rifaximin". The gene discussed is ALB; the disease is hereditary elliptocytosis.